Severe Menopause Symptoms Tied to Cognitive Impairment
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 20, 2024 -- Severe menopausal symptoms in postmenopausal women are associated with cognitive impairment, according to a study published online Aug. 13 in Menopause.
Andrés Calle, M.D., from Universidad Indoamérica in Quito, Ecuador, and colleagues evaluated the association between menopausal symptoms and cognitive decline in postmenopausal women. The analysis included 1,287 postmenopausal women (mean age, 55.5 years) attending gynecological consultations across nine Latin American countries.
The researchers found that 15.3 percent of women with mild cognitive impairment (MCI) exhibited significantly more intense menopausal symptoms versus those without MCI (Menopause Rating Scale [MRS] total score, 15.24 versus 10.53, respectively). There was a significant association between severe menopausal symptoms (MRS total score, ≥14 points) and MCI. Lower odds of MCI were seen with lower body mass index (odds ratio [OR], 0.96), sexual activity (OR, 0.70), physical exercise (OR, 0.55), menopausal hormone therapy use (OR, 0.36), and higher education level (OR, 0.31).
"This study showed a potential link between severe menopause symptoms and cognitive impairment in midlife women," Stephanie Faubion, M.D., medical director of The Menopause Society, said in a statement. "The results also suggest a protective effect of lower body mass index, higher educational level, physical exercise, hormone therapy use, and sexual activity on cognition, highlighting the potential for targeted interventions to protect and preserve cognitive function in menopausal women."
Two authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease
THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States...
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
Overwork Tied to Structural Changes in Brains of Health Care Workers
MONDAY, May 19, 2025 -- Overwork in health care workers is associated with structural brain changes, particularly in regions linked to cognition and emotion, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.